ST. JOHNS WORT
Its safe for most people, but be aware of drug-combination risks.
May/June 2000
By Amy Baugh-Meyer and Kelli Rosen
 |
St. John’s wort is generally safe, but use caution when taking certain medications.
|
On February 10, the newspapers were buzzing
about new pieces of research involving St. John’s wort. Headlines
read, “Two studies fault St. John’s wort”; “Popular herb becomes
target of warning”; and “FDA cautions about St. John’s wort.”
RELATED ARTICLES
Wishing you a safe New Year January/February 2001 By Robert Rountree, M.D. H erb-drug inte...
Looking for a special pick-me-up on a cold afternoon? Try this delicious Middle Eastern coffee for ...
A quick Q&A with The Herb Companion's founder, Linda Ligon....
Causing all the hype were two small samples, of eight and two
people respectively, which found that St. John’s wort (Hypericum
perforatum) may interfere with drugs used to treat HIV patients and
people who have had heart transplants.
“The mass media is quick to jump on any negative tidbit they can
get on an herb,” says Steven Foster, Herbs for Health lead
editorial adviser and author of 101 Medicinal Herbs (Interweave
Press, 1998).
However, Foster and other herbalists were not surprised by the
findings.
Mark Blumenthal, executive director of the American Botanical
Council and an Herbs for Health adviser, says other data has been
published prior to these studies that backs up theories that St.
John’s wort affects drug metabolism.
“It’s inevitable to get new reports of drug interactions that
could not have been predicted in clinical studies, because more
people in the general population are now taking St. John’s wort,”
says Blumenthal. “We’re probably going to see even more
interactions in the future.”
What the research means
The HIV researchers gave eight HIV-negative subjects a protease
inhibitor called indinavir for three days. On the third day, the
subjects began taking St. John’s wort, then they took both
indinavir and the herb for two weeks. Research showed that blood
concentrations of indinavir dropped an average of 57 percent when
taken with St. John’s wort. In the second sample, two Swiss heart
transplant patients were found to have lower-than-normal levels of
the antirejection drug cyclosporine in their blood after taking St.
John’s wort.
Robert Rountree, M.D., explains the effects. “Both indinavir and
cyclosporine are metabolized by cytochrome 3A4—part of the
cytochrome enzyme system, which metabolizes numerous drugs. I
suspect that there is some ingredient in standardized St. John’s
wort that induces, or activates, this enzyme, leading to faster
clearing of the drug from the bloodstream.”